Mandom Valuation
Is MDOM.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MDOM.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MDOM.F ($9) is trading above our estimate of fair value ($6.44)
Significantly Below Fair Value: MDOM.F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MDOM.F?
Key metric: As MDOM.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is MDOM.F's PE Ratio? | |
|---|---|
| PE Ratio | 65.5x |
| Earnings | JP¥958.00m |
| Market Cap | JP¥62.77b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.7x |
| Enterprise Value/EBITDA | 7.1x |
| PEG Ratio | 1.7x |
Price to Earnings Ratio vs Peers
How does MDOM.F's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 24x | ||
THRN Thorne HealthTech | 27.1x | 57.2% | US$550.6m |
HKHC Horizon Kinetics Holding | 37.6x | n/a | US$720.3m |
USNA USANA Health Sciences | 14x | -0.7% | US$760.5m |
NATR Nature's Sunshine Products | 17.4x | 6.4% | US$295.6m |
MDOM.F Mandom | 65.5x | 37.8% | US$62.8b |
Price-To-Earnings vs Peers: MDOM.F is expensive based on its Price-To-Earnings Ratio (65.5x) compared to the peer average (37x).
Price to Earnings Ratio vs Industry
How does MDOM.F's PE Ratio compare vs other companies in the US Personal Products Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: MDOM.F is expensive based on its Price-To-Earnings Ratio (65.5x) compared to the US Personal Products industry average (27.1x).
Price to Earnings Ratio vs Fair Ratio
What is MDOM.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 65.5x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MDOM.F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Kimberly-Clark de México S. A. B. de C. V
Mex$86.6b
Manufactures, distributes, and sells disposable products in Mexico.
KCDM.F
Mex$1.37
7D
-5.8%
1Y
n/a
Beauty Health
US$176.3m
Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.
SKIN
US$1.42
7D
-9.3%
1Y
-42.0%
Reynolds Consumer Products
US$5.8b
Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.
REYN
US$27.76
7D
1.1%
1Y
6.5%